ÂÜÀòÂÒÂ×

Ruiqi Yang currently serves as the Senior Manager of Strategic Marketing at IGNIS Therapeutics (Shanghai) Co., Ltd, focusing on the launch of new products in the central nervous system (CNS) field since January 2022. Prior to this role, Ruiqi worked at MSD as a Product Manager, successfully launching the colorectal cancer indication for Keytruda starting in March 2021. Ruiqi's experience also includes a tenure at Johnson & Johnson from August 2016 to March 2021, where responsibilities included managing the Risperdal and Invega brands as a Product Manager, along with brand ownership for Tylenol and Motrin as an Associate Product Manager and Marketing Management Trainee. An early career at Bosch consisted of an internship in Asian Pacific marketing during June to October 2014. Ruiqi holds a Master of Arts degree in English Language and Literature from Zhejiang University, earned in 2016.